Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus
Neuropsychopharmacology Reports · 2025-03 · 45 (1)
DOI: 10.1002/npr2.12525 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 05.01.2025. Verfasst von Hayder M Al-Kuraishy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad, Iraq. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Protein Precursor, Blood Platelets. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is the most common neurodegenerative disease associated with the development of dementia. The hallmarks of AD neuropathology are accumulations of amyloid peptide (Aβ) and neurofibrillary tangles (NFTs). Aβ is derived from the processing of APP (amyloid beta precursor protein) by BACE1 (beta‐secretase 1) and γ‐secretase through an amyloidogenic pathway. However, processing of APP by ADAM10/α‐secretase (ADAM metallopeptidase domain 10) enzymes through a non‐amyloidogenic pathway produces soluble APP alpha (sAPPα), which has a neuroprotective effect. It has been shown that activated platelets are implicated in the pathogenesis of AD, which also increases platelet activation. Under physiological conditions, platelets regulate synaptic plasticity and increase neuronal differentiation by regulation of the inflammatory response. However, overactivated platelets contribute to the pathogenesis of AD. Activated platelets represent the main source of circulating APP and Aβ that may be involved in AD neuropathology. Therefore, there is a close relationship between AD neuropathology and activated platelets. This review discusses the potential role of platelets in the pathogenesis of AD, and how targeting of activated platelets may reduce AD neuropathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad, Iraq.
- Division of Biotechnology, Department of Applied Sciences, University of Technology, Baghdad, Iraq.
- Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah, Qassim, Saudi Arabia.
- Department of Biology, College of Science, Al-Mustaqbal University, Hillah, Iraq.
- Jabir ibn Hayyan Medical University, Najaf, Iraq.
- Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, Bisha, Saudi Arabia.
ORCID-Profile: Ghassan M Sulaiman
Förderung
- NIGMS NIH HHS
Zitieren
APA
Al-Kuraishy, H. M., Sulaiman, G. M., Mohammed, H. A., Dawood, R. A., Albuhadily, A. K., Al-Gareeb, A. I., Abomughaid, M. M., & Klionsky, D. J. (2025). Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus. Neuropsychopharmacology Reports, 45(1). https://doi.org/10.1002/npr2.12525
Vancouver
Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Dawood RA, Albuhadily AK, Al-Gareeb AI, et al. Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus. Neuropsychopharmacology Reports. 2025;45(1). doi:10.1002/npr2.12525
BibTeX
@article{AlKuraishy2025,
author = {Al-Kuraishy, Hayder M and Sulaiman, Ghassan M and Mohammed, Hamdoon A and Dawood, Retaj A and Albuhadily, Ali K and Al-Gareeb, Ali I and Abomughaid, Mosleh M and Klionsky, Daniel J},
title = {Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus},
journal = {Neuropsychopharmacology Reports},
year = {2025},
volume = {45},
number = {1},
doi = {10.1002/npr2.12525}
}
EUVIMED